DE69819748D1 - Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen - Google Patents

Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Info

Publication number
DE69819748D1
DE69819748D1 DE69819748T DE69819748T DE69819748D1 DE 69819748 D1 DE69819748 D1 DE 69819748D1 DE 69819748 T DE69819748 T DE 69819748T DE 69819748 T DE69819748 T DE 69819748T DE 69819748 D1 DE69819748 D1 DE 69819748D1
Authority
DE
Germany
Prior art keywords
blies
composition
medicines
previous
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69819748T
Other languages
English (en)
Other versions
DE69819748T2 (de
Inventor
L Levine
J Bologna
Ziegler Dominique De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia Laboratories Bermuda Ltd
Original Assignee
Columbia Laboratories Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26738031&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69819748(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Columbia Laboratories Bermuda Ltd filed Critical Columbia Laboratories Bermuda Ltd
Application granted granted Critical
Publication of DE69819748D1 publication Critical patent/DE69819748D1/de
Publication of DE69819748T2 publication Critical patent/DE69819748T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
DE69819748T 1997-09-12 1988-09-08 Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen Expired - Lifetime DE69819748T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5878997P 1997-09-12 1997-09-12
US58789P 1997-09-12
US09/145,172 US6126959A (en) 1997-09-12 1998-09-01 Pharmaceutical composition for treating dysmenorrhea and premature labor
US145172 1998-09-01
PCT/US1998/018538 WO1999013862A2 (en) 1997-09-12 1998-09-08 A pharmaceutical composition for treating dysmenorrhea and premature labor

Publications (2)

Publication Number Publication Date
DE69819748D1 true DE69819748D1 (de) 2003-12-18
DE69819748T2 DE69819748T2 (de) 2004-09-30

Family

ID=26738031

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69819748T Expired - Lifetime DE69819748T2 (de) 1997-09-12 1988-09-08 Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Country Status (20)

Country Link
US (2) US6126959A (de)
EP (1) EP1011632B1 (de)
JP (1) JP2002503637A (de)
KR (1) KR100575386B1 (de)
CN (1) CN1186009C (de)
AT (1) ATE253892T1 (de)
AU (1) AU738460B2 (de)
BR (1) BR9812134A (de)
CA (1) CA2303339C (de)
DE (1) DE69819748T2 (de)
DK (1) DK1011632T3 (de)
ES (1) ES2210813T3 (de)
HK (1) HK1025055A1 (de)
HU (1) HUP0003784A3 (de)
IL (1) IL134564A0 (de)
NO (1) NO329203B1 (de)
NZ (1) NZ502926A (de)
PT (1) PT1011632E (de)
RO (1) RO120814B1 (de)
WO (1) WO1999013862A2 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344732B2 (en) * 2002-01-10 2008-03-18 Kimberly-Clark Worldwide, Inc. Medicated tampon
US7341737B2 (en) * 1997-06-11 2008-03-11 Kimberly-Clark Worldwide, Inc. Medicated tampon
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
US6818672B1 (en) * 1999-10-05 2004-11-16 Columbia Laboratories, Inc. Treating endometriosis or infertility, or improving fertility
UA74168C2 (uk) * 1999-10-05 2005-11-15 Коламбіа Леборетеріс (Бермуда) Лімітед Лікування ендометріозу або безпліддя, або покращення плідності та застосування бета-адренергічного агоніста для виробництва лікарського засобу
US6479045B2 (en) 1999-12-22 2002-11-12 Columbia Laboratories, Inc. Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US7709026B2 (en) 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en) * 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
FR2841223B1 (fr) 2002-06-19 2004-10-15 Sleever Int Enveloppe d'emballage d'objets(s) en materiau thermoretractable a face interne ou externe essentiellement lisse
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
PE20040134A1 (es) * 2002-07-25 2004-03-06 Pharmacia Corp Forma de dosificacion de una vez al dia de pramipexol
PE20040321A1 (es) * 2002-08-22 2004-07-15 Novartis Consumer Health Sa Composicion topica que comprende diclofenaco
ATE400270T1 (de) * 2002-12-18 2008-07-15 Ferrer Int Pharmazeutische zusammensetzungen mit sertaconazol für vaginale verwendung
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1660101A4 (de) * 2003-08-21 2010-02-24 Access Pharma Inc Flüssige formulierungen zur prävention und behandlung von schleimhauterkrankungen und störungen
EP2431026A1 (de) * 2004-08-13 2012-03-21 Boehringer Ingelheim International GmbH Pelletformulierung mit verlängerter Wirkstofffreigabe, die Pramipexol oder ein pharmazeutisch unbedenkliches Salz davon enthält, Verfahren zu deren Herstellung und deren Verwendung
ES2355735T5 (es) * 2004-08-13 2014-06-27 Boehringer Ingelheim International Gmbh Formulación en comprimidos de liberación extendida que contiene pramipexol o una de sus sales farmac�uticamente aceptables, método para su fabricación y su uso
US7481815B2 (en) * 2004-09-23 2009-01-27 Synthes (U.S.A.) Coplanar X-ray guided aiming arm for locking of intramedullary nails
US7744556B2 (en) 2005-03-25 2010-06-29 Kimberly-Clark Worldwide, Inc. Delivery tube assembly for an applicator
US7993667B2 (en) 2005-03-25 2011-08-09 Kimberly-Clark Worldwide, Inc. Methods of manufacturing a medicated tampon assembly
US7919453B2 (en) 2005-03-25 2011-04-05 Kimberly-Clark Worldwide, Inc. Dosage cap assembly for an applicator
US7708726B2 (en) 2005-04-28 2010-05-04 Kimberly-Clark Worldwide, Inc. Dosage form cap for an applicator
CA2641665A1 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Modified release formulation
US20090098202A1 (en) * 2006-02-10 2009-04-16 Boehringer Ingelheim International Gmbh Extended Release Formulation
WO2008091592A1 (en) 2007-01-22 2008-07-31 Targacept, Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
US8445436B2 (en) * 2007-12-03 2013-05-21 Florida State University Research Foundation, Inc. Oxytocin and melatonin compositions and associated methods for inducing labor
US8992589B2 (en) 2007-12-03 2015-03-31 The Florida State University Research Foundation, Inc. Using light to regulate uterine contractions
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
BRPI0803568B8 (pt) * 2008-08-14 2021-05-25 Biolab San Us Farm Ltda composição mucoaderente
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
GB2484977A (en) * 2010-10-29 2012-05-02 Biocopea Ltd Treatment of a Th-1 mediated disease
MX2014000066A (es) 2011-06-28 2014-05-01 Medicis Pharmaceutical Corp Formulaciones mucoadhesivas en gel de alta dosificación de metronidazol de base acuosa y su uso para tratar la vaginosis bacteriana.
AU2016356884A1 (en) * 2015-11-16 2018-06-21 Fundación Para La Investigación Médica Aplicada Novel compounds as inhibitors of dna methyltransferases

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925320A (ja) * 1982-08-02 1984-02-09 Watanabe Yakuhin Kogyo Kk 薬物投与用貼付剤
AU565354B2 (en) * 1983-11-14 1987-09-10 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
EP0147780A3 (de) * 1984-01-03 1987-03-11 Merck & Co. Inc. Vorrichtung zur Freisetzung von Arzneistoffen
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
USD345211S (en) 1992-04-06 1994-03-15 Columbia Laboratories, Inc. Dispensing vial for feminine hygiene products
US5508045A (en) * 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
USD375352S (en) 1994-03-14 1996-11-05 Columbia Laboratories, Inc. Dispensing vial for feminine hygiene products
FR2720276B1 (fr) * 1994-05-24 1997-09-05 Christophe Boyer Nouvelle utilisation thérapeutique des agents bétamimétiques et médicament en contenant.
US5667492A (en) 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
FR2725343B1 (fr) * 1994-10-10 1998-01-02 Jean Claude Attali Complexe insecticide et parasiticide, et procede de desinsectisation et de destruction des ectoparasites
US5985861A (en) 1996-11-04 1999-11-16 Columbia Laboratories, Inc. Progesterone for treating or reducing ischemia
WO1998023292A1 (en) * 1996-11-29 1998-06-04 Monsanto Company Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
NO329203B1 (no) 2010-09-13
RO120814B1 (ro) 2006-08-30
ES2210813T3 (es) 2004-07-01
DK1011632T3 (da) 2004-03-29
US20020012677A1 (en) 2002-01-31
KR20010030588A (ko) 2001-04-16
CA2303339A1 (en) 1999-03-25
NZ502926A (en) 2001-10-26
NO20001287L (no) 2000-03-10
KR100575386B1 (ko) 2006-05-03
NO20001287D0 (no) 2000-03-10
US6699494B2 (en) 2004-03-02
CA2303339C (en) 2006-12-12
IL134564A0 (en) 2001-04-30
HUP0003784A3 (en) 2001-12-28
EP1011632B1 (de) 2003-11-12
WO1999013862A2 (en) 1999-03-25
CN1186009C (zh) 2005-01-26
DE69819748T2 (de) 2004-09-30
CN1270514A (zh) 2000-10-18
PT1011632E (pt) 2004-03-31
US6126959A (en) 2000-10-03
ATE253892T1 (de) 2003-11-15
EP1011632A2 (de) 2000-06-28
BR9812134A (pt) 2000-07-18
WO1999013862A3 (en) 1999-05-14
AU9131198A (en) 1999-04-05
JP2002503637A (ja) 2002-02-05
AU738460B2 (en) 2001-09-20
HUP0003784A2 (hu) 2001-08-28
HK1025055A1 (en) 2000-11-03

Similar Documents

Publication Publication Date Title
DE69819748D1 (de) Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
DE69805973D1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
ATE146677T1 (de) Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
ATE171873T1 (de) Antiglucocorticoidsteroide zur behandlung von angststörungen
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
DE69107493D1 (de) Arzneimittel zur transdermalen Verabreichung von Nitroglycerin.
ATE152628T1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
DE69316013D1 (de) Verwendung von phosphinate zur behandlung der osteoporose
ATE221391T1 (de) Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
UA32457C2 (uk) Лікарський засіб (варіанти) і спосіб медикаментозного впливу на організм
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
ATE190843T1 (de) Zubereitungen zur behandlung von impotenz, die ein alpha-1 inhibitor und ein alpha-2 inhibitor enthalten
BR9506748A (pt) Compostos preparação farmacêutica utilização de um composto e processos para o tratamento de um indivíduo sofrendo de dor e para a preparação de um composto
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
DE69526584T2 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
MY116275A (en) A pharmaceutical composition for treating dysmenorrhea and premature labor
DE69927599D1 (de) Verwendung von wachstumshormon und analoga davon für die behandlung von säugern mit familiärer hypercholesterolämie
DE19775036I2 (de) Arzneimittel zur Behandlung von Augenentzündung.
MX9606137A (es) Composiciones y metodos para el tratamiento de tumores.
ATE59776T1 (de) Pharmazeutische zusammensetzung und behandlung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition